← SynDRA
TECALCET
SynDRA canonical compound SYN0002801 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CASR |
|---|
| Mechanism of action | calcium-sensing receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- CASR MODULATOR
- Calcium sensing receptor modulator
- CASR POSITIVE ALLOSTERIC MODULATOR
- calcium-sensing receptor agonist
- CASR AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HTR1A
- SLC6A2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- OPRK1
- OPRM1
- HTR5A
- SIGMAR1
- ADRB3
- GPR65
- ADRA2C
- ADRA2B
- HRH1
- HRH2
- TMEM97
- DRD3
- HTR1D
- HTR1B
- HTR1E
- HTR3A
- ADGRF1
- HTR7
- MUTYH
- HRH4
- OGG1
- OPRD1
- S1PR1
- SLC6A3
- SLC6A4
- SMUG1
- TDG
- NEIL1
- HDAC6
- HRH3
- ADRA1A
- ADRA1B
- ADRA1D
- ADRA2A
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Tecalcet [INN]
- R-568
- 8I16YLE4US
- NPS R568
- NPS-R-568
- UNII-8I16YLE4US
- 9IG
- (R)-2-Chloro-N-(1-(3-methoxyphenyl)ethyl)benzenepropanamine
- GTPL718
- SCHEMBL311950
- orb1738925
- SCHEMBL30092843
- SCHEMBL31424064
- ZVQUCWXZCKWZBP-CQSZACIVSA-N
- GLXC-07673
- BDBM50299670
- BDBM50432960
- AKOS040850283
- NCGC00344508-01
- NCGC00344508-03
- CS-0002493
- NS00116089
- BRD-K41662846-003-01-5
- NPS R-568
- R 568
- DTXCID4092754
- HY-10167A
- R 568 HCl
- AKOS024457812
- Norcalin
- DA-77308
- CS-0002492
- LS-31029
- D06020
- CHA17249
- 3HP28R98LC
- tecalcet hydrochloride
- N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine
Look up TECALCET in the interactive SynDRA portal →